VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,567,000 | -4.6% | 98,236 | -0.4% | 0.00% | 0.0% |
| Q3 2016 | $1,642,000 | +51.6% | 98,663 | +2.0% | 0.00% | +100.0% |
| Q2 2016 | $1,083,000 | +556.4% | 96,756 | +391.0% | 0.00% | – |
| Q1 2016 | $165,000 | -2.9% | 19,705 | +8.0% | 0.00% | – |
| Q4 2015 | $170,000 | -43.0% | 18,246 | -31.0% | 0.00% | – |
| Q3 2015 | $298,000 | -13.1% | 26,450 | -2.2% | 0.00% | – |
| Q2 2015 | $343,000 | +68.1% | 27,055 | +23.5% | 0.00% | – |
| Q1 2015 | $204,000 | -34.0% | 21,905 | +1.5% | 0.00% | – |
| Q4 2014 | $309,000 | +47.8% | 21,576 | +7.0% | 0.00% | – |
| Q3 2014 | $209,000 | -38.0% | 20,173 | -3.3% | 0.00% | – |
| Q2 2014 | $337,000 | -36.8% | 20,854 | -36.4% | 0.00% | -100.0% |
| Q1 2014 | $533,000 | -29.7% | 32,786 | -46.4% | 0.00% | 0.0% |
| Q4 2013 | $758,000 | +235.4% | 61,115 | +196.2% | 0.00% | – |
| Q3 2013 | $226,000 | -56.2% | 20,633 | -67.7% | 0.00% | -100.0% |
| Q2 2013 | $516,000 | – | 63,836 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |